TrialClinical and translational science2021

Effect of difelikefalin, a selective kappa opioid receptor agonist, on respiratory depression: A randomized, double-blind, placebo-controlled trial.

Eugene R Viscusi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.